Jan 09, 2017 12:30 pm UTC| Business
MENLO PARK, Calif., Jan. 09, 2017 -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system’s...
Jan 09, 2017 12:30 pm UTC| Business
-- Company Initiates Phase III “ADVOCATE” Clinical Trial for Complement Receptor Inhibitor Avacopan in ANCA Vasculitis; Development Path Outlined in Rare Kidney Disease for Chemokine Receptor Inhibitor ‘CCX140’ -- ...
Jan 09, 2017 12:30 pm UTC| Business
Statistically significant pharmacokinetic and pharmacodynamic differences of abuse potential were observed in the KP511.A01 Study CORALVILLE, Iowa, Jan. 09, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage...
Jan 09, 2017 12:30 pm UTC| Business
MINNEAPOLIS, Jan. 09, 2017 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases...
Jan 09, 2017 12:30 pm UTC| Business
WASHINGTON, Jan. 09, 2017 -- FTI Consulting, Inc. (NYSE:FCN) today announced the expansion of the firm’s Construction Solutions practice within the Forensic Litigation Consulting segment with the addition of eight...
francesca’s® Updates and Reaffirms Fourth Quarter 2016 Guidance Based on Holiday Results
Jan 09, 2017 12:30 pm UTC| Business
HOUSTON, Jan. 09, 2017 -- Francesca’s Holdings Corporation (NASDAQ:FRAN) today announced that the Company has updated and reaffirmed its guidance for the fourth quarter ending January 28, 2017 based on its holiday...
The European Patent Office grants patent for tasquinimod for treatment of multiple myeloma
Jan 09, 2017 12:08 pm UTC| Business
Lund January 9, 2017 - Active Biotech AB (Nasdag Stockholm: ACTI) announces today that the European Patent Office has decided to grant Active Biotech's patent application covering tasquinimod for use in the treatment of...